CCB
ROCM

Cutter & Co Brokerage’s ROCHESTER MEDICAL CORP ROCM Stock Holding History

Cutter & Co Brokerage’s Portfolio ROCM Stock Details ROCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-64,350
Closed -$948K – 233
2013
Q2 		$948K Buy
+64,350
New +$919K 0.45% 69

Other funds holding ROCM

GI
GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
LIM
Longfellow Investment Management Boston, Massachusetts $480M AUM 8% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
CCMU
Cheyne Capital Management (UK) London, United Kingdom $27.9M AUM 36.14% 1-Year Est. Return
TA
Teton Advisors Rye, New York $142M AUM 42.07% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GCIA
Gabelli & Co Investment Advisers Rye, New York $674M AUM 64.52% 1-Year Est. Return
PGIM
Pacific Global Investment Management Glendale, California $70.7M AUM 14.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Cutter & Co Brokerage's ROCM Position: Q3 2013 in Review

Cutter & Co Brokerage sold out of ROCHESTER MEDICAL CORP (ROCM) in Q3 2013, closing a stake of 64,350 shares — an estimated $948K sold.

Cutter & Co Brokerage first reported a position in ROCM in Q2 2013 and held it in 1 quarter. The position peaked at $948K in Q2 2013. 68 funds tracked by Wall St. Rank hold ROCM as of Q3 2013.

  • Cutter & Co Brokerage reported no remaining ROCHESTER MEDICAL CORP position as of Q3 2013 after selling out during the quarter.
  • Cutter & Co Brokerage sold 64,350 ROCHESTER MEDICAL CORP shares in Q3 2013, an estimated $948K.
  • Cutter & Co Brokerage first reported a position in ROCHESTER MEDICAL CORP in Q2 2013 and held it in 1 quarter.
  • Cutter & Co Brokerage's ROCHESTER MEDICAL CORP position peaked at $948K in Q2 2013.
  • 68 funds tracked by Wall St. Rank held ROCHESTER MEDICAL CORP as of Q3 2013.

Based on Cutter & Co Brokerage's 13F filing for Q3 2013, filed 28 Oct 2013.